科研日报 2026-03-02
📅 Daily Report - 2026-03-02
今日筛选出 745 条内容,来自 2 个来源
🤖 今日AI智能总结
🧬 数据前沿
今日焦点: 研究揭示IL-17驱动的卵巢癌微环境重塑及IL-1beta/IL-23信号通路在抵抗非结核分枝杆菌中的关键作用。
主要方向:
- 肿瘤免疫微环境调控:聚焦胆管癌、卵巢癌、淋巴结和肾移植排斥反应中的免疫细胞互作和信号通路。
- 疾病机制探索:深入解析巨噬细胞在非结核分枝杆菌感染、主动脉瓣狭窄进展及脑膜病变中的作用。
- 致病性血管通路研究:关注高内皮小静脉(HEVs)在肿瘤免疫逃逸中的作用。
技术亮点:
- 空间转录组学(Spatial Transcriptomics)和单细胞RNA测序(scRNA-seq)技术广泛应用于解析复杂生物体系的细胞异质性和空间信息。
- PRO-cap技术用于高精度绘制基因转录起始位点。
🧪 博客更新
今日焦点: 科学家发现新型细菌“杀毒开关”有望对抗超级细菌;咖啡与CRISPR基因编辑结合,或可用于癌症治疗。
主要方向:
- 探索药物(Ozempic/Wegovy)新成分(SNAC)对肠道健康的影响。
- 开发针对耐药细菌的新型治疗策略。
- 利用基因编辑技术实现癌症细胞的靶向干预。
技术亮点:
- 发现病毒利用特定机制关闭细菌关键蛋白,为开发新型抗生素提供思路。
- 整合咖啡因与CRISPR技术,构建细胞程序化调控系统。
📚 分类浏览
🧬 数据前沿 (742条)
详细内容(前10条)
1. ⭐ GSE316402 帕博利珠单抗联合粒细胞巨噬细胞集落刺激因子治疗晚期胆道癌的 II 期试验 [空间转录组学]
- ✍️ 作者:未知作者
- 🏷️ 关键词:cancer、macrophage、spatial、spatial transcriptomics、transcriptomics
- 📝 描述:Contributors : Robin K Kelley ; Paige Bracci ; John D Gordan ; Spencer C Behr ; Zoe Quandt ; Chloe E Atreya ; Wesley Kidder ; Andrew H Ko ; Huat Lim ; Katherine Van Loon ; Nia Adeniji ; Alan P Venook ; Lawrence Fong ; Bridget P KeenanSeries Type : OtherOrganism : Homo sapiensImmune checkpoint inhibitors have limited activity as monotherapy in biliary cancers. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a pleiotropic immune cell growth factor which resulted in prolonged survival when combined with ipilimumab in melanoma. We conducted a single-center, phase II trial to evaluate the efficacy and safety of combining GM-CSF with pembrolizumab in patients with advanced biliary cancers after prior standard chemotherapy but no prior immune checkpoint inhibitor. Pembrolizumab 200 mg was administered intravenously in 21-day cycles, along with two cycles of GM-CSF 250 µg subcutaneously days 1 through 14. The primary endpoint was objective response rate. Among 42 patients enrolled, the median age was 61 years, 67% had intrahepatic cholangiocarcinoma, 90% had stage IV disease, and 24% had underlying viral hepatitis. The confirmed objective response rate was 12% (95% confidence interval: 4, 26), including two patients with complete response, and 26% of patients had progression-free survival ongoing at 6 months. Treatment was well-tolerated with treatment-related grade 3-4 events in 7% and treatment-related serious adverse events in 10%. Tumor PD-L1 expression was present in 46% and was associated with a higher rate of 6-month progression-free survival. Paired tumor biopsies showed upregulation of CD8+ T cell populations and antigen processing pathways after the addition of GM-CSF. In conclusion, the addition of GM-CSF to pembrolizumab was well-tolerated but did not meet the pre-specified response rate for efficacy. A subset of patients experienced deep responses and prolonged stable disease. GM-CSF elicited changes in the tumor immune microenvironment that could guide future combination approaches.
- 🔗 查看原文
2. ⭐ GSE319959 IL-17 驱动的肿瘤细胞内在炎症编程在卵巢透明细胞癌中创造了有利于免疫疗法的微环境 [scRNA-Seq]
- ✍️ 作者:未知作者
- 🏷️ 关键词:tumor、carcinoma、regex:immuno(logy|therapy|suppression)、scRNA
- 📝 描述:Contributors : Kosuke Murakami ; Shiki Takamura ; Chiho Miyagawa ; Kazuhiro Kakimi ; Noriomi MatsumuraSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusOvarian clear cell carcinoma (OCCC) is a chemoresistant subtype of ovarian cancer with limited effective therapeutic options. Although immune checkpoint inhibitors (ICIs) have shown little benefit in unselected ovarian cancer populations, clinical activity observed in a subset of OCCC patients suggests the presence of a histotype-specific immune vulnerability that remains poorly defined. To elucidate this biology, we integrated transcriptomic analyses from multiple independent human OCCC cohorts with immunohistochemical profiling and mechanistic studies using an immunocompetent syngeneic OCCC mouse model. Tumor cell–intrinsic and microenvironmental responses to IL-17 were investigated through in vitro stimulation assays, in vivo IL-17 administration, single-cell RNA sequencing of tumor-infiltrating T cells, and immune checkpoint blockade in a Th17-biased partial chimera model. OCCC was characterized as an IL-6–high tumor entity with a globally immune-sparse but CD4⁺ T-cell–skewed tumor immune microenvironment. Transcriptomic analyses identified a Th17-associated program marked by elevated RORC expression in a subset of tumors. Across large clinical cohorts, an IL17A^high subset demonstrated a T cell–inflamed gene expression profile independent of microsatellite instability and tumor mutational burden; however, this phenotype was not associated with survival in untreated disease. Mechanistically, IL-17 directly activated NF-κB–dependent inflammatory programs in OCCC tumor cells, inducing cytokines involved in T-cell recruitment and activation. In vivo, IL-17 remodeled the immune microenvironment, increasing infiltration and activation of both CD4⁺ and CD8⁺ T cells. Single-cell profiling further revealed expansion of Th17/Tfh-like CD4⁺ T cells and cytotoxic, non-terminally exhausted CD8⁺ T cells. Consistent with these findings, anti–PD-L1 therapy significantly improved survival exclusively in Th17-biased partial chimera mice. Collectively, these results demonstrate that a Th17-biased, IL-17–responsive immune contexture in OCCC engages tumor cell–intrinsic NF-κB inflammatory signaling to prime antitumor T-cell states and enable checkpoint blockade efficacy. This immune biology is predictive rather than prognostic, supporting a biomarker-driven immunotherapy strategy for OCC…
- 🔗 查看原文
3. ⭐ GSE290965 巨噬细胞介导的 IL1beta/IL23 信号传导调节针对非结核分枝杆菌的 γ δ (γδ) T 细胞免疫 [scRNA-seq]。
- ✍️ 作者:未知作者
- 🏷️ 关键词:immunity、T cell、macrophage、scRNA
- 📝 描述:Series Type : Expression profiling by high throughput sequencingOrganism : Mus musculusMechanistic Insights. Our study reveals the crucial role of gammadelta T cells in non-tuberculous mycobacteria (NTM) infection. We observed a significant increase and activation of gammadelta T cells in mice infected with MAB or with MAB infection combined with pulmonary fibrosis. Depletion of gammadelta T cells worsened the infection, while transfer of gammadelta T cells reversed this effect. Mechanistically, we found that MAB infection stimulates macrophages to produce IL-1beta and IL-23, which promotes the expansion of gammadelta T17 cells. MAB can also directly activate gammadelta T cells, leading to the clearance of MAB through an IL-17A-dependent pathway. Our findings suggest that gammadelta T cells represent a potential therapeutic target for NTM infections.
- 🔗 查看原文
4. ⭐ GSE290963 巨噬细胞介导的 IL1beta/IL23 信号传导调节针对非结核分枝杆菌的 γ δ (γδ) T 细胞免疫 [RNA-seq]。
- ✍️ 作者:未知作者
- 🏷️ 关键词:immunity、T cell、macrophage、RNA-seq
- 📝 描述:Series Type : Expression profiling by high throughput sequencingOrganism : Mus musculusMechanistic Insights. Our study reveals the crucial role of gammadelta T cells in non-tuberculous mycobacteria (NTM) infection. We observed a significant increase and activation of gammadelta T cells in mice infected with MAB or with MAB infection combined with pulmonary fibrosis. Depletion of gammadelta T cells worsened the infection, while transfer of gammadelta T cells reversed this effect. Mechanistically, we found that MAB infection stimulates macrophages to produce IL-1beta and IL-23, which promotes the expansion of gammadelta T17 cells. MAB can also directly activate gammadelta T cells, leading to the clearance of MAB through an IL-17A-dependent pathway. Our findings suggest that gammadelta T cells represent a potential therapeutic target for NTM infections.
- 🔗 查看原文
5. ⭐ GSE318650 scRNA测序数据来自CTL组、巨噬细胞清除后5天和8周的软脑膜、皮质和硬脑膜细胞。
- ✍️ 作者:未知作者
- 🏷️ 关键词:macrophage、sequencing、scRNA
- 📝 描述:Contributors : Maximilian Fliegauf ; Lukas Amann ; Jovana Cupovic ; Roman Sankowski ; Marco PrinzSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusPerivascular and leptomeningeal macrophages are non-parenchymal macrophages summarized as central nervous system (CNS)-associated macrophages (CAMs) that mediate immune responses at brain boundaries. Both, CAMs and juxtaneuronal microglia are derived from prenatal yolk sac (YS) precursors, long-living and maintain their populations by homeostatic self-renewal without input from the periphery. Whereas microglia have been shown to be repopulated by CNS endogenous remnants of the same lineage following depletion, the renewal biology of CAMs is still poorly understood. Here, by combining multilineage myeloid fate mapping, bulk and single-cell profiling and high resolution confocal imaging, we show that the repopulation is strikingly different between CAMs and microglia. In contrast to microglia, CAMs do not renew exclusively cell-autonomously, but transiently utilize CCR2+Ly-6C+ monocytes after niche induction in an integrin-dependent manner. Remarkably and unlike repopulated microglia, replenished monocyte-derived CAMs remain transcriptionally and functionally distinct from their YS-derived counterparts. Finally, we established a protocol that allows to selectively exchange CAMs modulating disease response without functionally affecting parenchymal microglia. These new insights into the biology of the CNS immune system offer completely new therapeutic avenues for diverse neuroinflammatory and neurodegenerative diseases.
- 🔗 查看原文
6. ⭐ GSE308452 血浆蛋白质组学可改善癌症患者的血栓形成预测,并揭示一条可靶向的IL-17驱动的内皮细胞激活通路
- ✍️ 作者:未知作者
- 🏷️ 关键词:cancer、proteomics、pathway
- 📝 描述:Contributors : Brake Marisa ; Schulman Sol ; Zwicker JeffSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThrombosis remains a major cause of morbidity and mortality in cancer patients. Existing risk models fail to reliably predict venous thromboembolism (VTE), underscoring the need for more accurate predictive models. In this study, we conducted a high-throughput proteomic analysis of 1,105 plasma proteins from newly diagnosed lung and gastric cancer patients prospectively monitored for VTE development. Utilizing a Bayesian probabilistic machine learning approach, we developed a predictive model incorporating 11 protein biomarkers and five clinical parameters (age, sex, history of VTE, body mass index, and hemoglobin), which significantly outperformed the Khorana prediction model. Orthogonal validation in an external placebo cohort from a phase III trial confirmed the model’s predictive power. Further investigation into the mechanistic role of CD200R1, a checkpoint receptor limiting leukocyte inflammatory response that contributed strongly to the model, showed that reduced levels in plasma correlated with higher D-dimer and thrombosis risk. In CD200R1-deficient mice, elevated thrombin-antithrombin complexes confirmed a prothrombotic state characterized by increased IL-17A and endothelial inflammation. Administration of anti-IL-17A antibodies to CD200R1 deficient mice normalized thrombin generation in vivo, and a meta-analysis of human clinical IL-17A inhibitory antibody studies confirmed antithrombotic activity. These findings improve the prediction of thrombosis in cancer and highlight the utility of plasma proteomics to identify unanticipated mechanistic insights and therapeutic targets in thrombo-inflammatory disease.
- 🔗 查看原文
7. ⭐ GSE306742 肿瘤相关高内皮静脉通过 ALOX12 驱动淋巴结门静脉特异性免疫逃逸 [转移性淋巴结]
- ✍️ 作者:未知作者
- 🏷️ 关键词:immune、lymph、regex:lymph(o|atic)?
- 📝 描述:Contributors : Qidong Xia ; Shicheng SuSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusHigh-endothelial-venules (HEVs) offer another entry point for tumor metastasis in mice. To investigate whether HEVs and non-specialized blood vessels exert different effects on disseminating tumor cells, we enriched EO771 derivatives HEVM3 (preferentially metastasize through HEVs) cells and BVM3 (preferentially metastasize through blood vessels) cells. To further explore potential factor(s) that influence tumor cells, we isolated blood vessel endothelial cells (BECs) in metastatic lymph nodes from six C57BL/6J mice and analyzed them with single-cell RNA sequencing.
- 🔗 查看原文
8. ⭐ GSE306111 人类FALD和正常肝脏的空间转录组学
- ✍️ 作者:未知作者
- 🏷️ 关键词:spatial、spatial transcriptomics、transcriptomics
- 📝 描述:Contributors : Seiya Kato ; Hayato Hikita ; Tetsuo TakeharaSeries Type : OtherOrganism : Homo sapiensSpatial transcriptomic analysis was performed on Fontan-associated liver disease (FALD) and normal livers using CosMx Spatial Molecular Imager.
- 🔗 查看原文
9. ⭐ GSE303904 单细胞转录组学揭示肾移植排斥反应的早期免疫图谱,并指出 Ccl3-Ccr5 为治疗靶点
- ✍️ 作者:未知作者
- 🏷️ 关键词:immune、single-cell、transcriptomics
- 📝 描述:Contributor : Lijun YangSeries Type : Expression profiling by high throughput sequencingOrganism : Rattus norvegicusBackground Acute rejection is a primary determinant of long-term allograft survival, and the early-stage immune cell dynamics with local intercellular communication during this process require further elucidation.Methods We performed single-cell RNA sequencing (scRNA-seq) on CD45+ immune cells isolated from rat renal allografts during the early phase of acute rejection (days 0, 1, 3, and 7). Using unsupervised clustering, functional enrichment analysis, cellular trajectory inference, and intercellular communication network mapping, we delineated the immune cell dynamics and local communication networks at single-cell resolution. Our findings were subsequently validated through multiplex immunofluorescence and therapeutic intervention experiments.Results Macrophages constituted the dominant immune population during acute rejection. Sub-clustering analysis revealed a rapid expansion of the Isg15+Mac subset by post-transplant day 1, which persisted at elevated levels thereafter. Functional enrichment and trajectory inference demonstrated the pro-inflammatory properties of Isg15+Mac, implicating this subset in acute rejection. Cell-cell communication analysis identified Ccl3-Ccr5 ligand-receptor interactions between Isg15+Mac and T cells. Multiplex immunofluorescence confirmed abundance of Isg15+Mac within the allografts. Moreover, We alleviated the acute rejection after kidney transplantation using the FDA-approved Ccr5 blocker Maraviroc.Conclusions Our study establishes an in-depth, early-stage immune landscape of renal transplantation, uncovering the Isg15+Mac subset as a critical driver of acute rejection via the Ccl3-Ccr5 axis. And also indicating that Maraviroc may potentially be a therapeutic candidate for transplant rejection.
- 🔗 查看原文
10. ⭐ GSE291890 单细胞 RNA 测序揭示巨噬细胞参与主动脉瓣狭窄进展
- ✍️ 作者:未知作者
- 🏷️ 关键词:macrophage、sequencing、single-cell
- 📝 描述:Contributors : Tomoyo Hamana ; Takuo EmotoSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensIntroduction: Calcific aortic stenosis (AS) is an age-related progressive disease with increasing global prevalence. Although chronic inflammation is a key factor in its pathogenesis, the detailed immune cell profiles and their interactions with non-immune cells remain poorly understood. This study aimed to characterize the immune cell landscape in calcific AS at a single-cell level and evaluate the potential of anti-inflammatory therapy. Methods: Human aortic valve samples were obtained from four patients with non-calcified aortic regurgitation (AR) and 11 patients with AS undergoing surgical aortic valve replacement. Single-cell 3’ gene expression sequencing (scRNA-seq (3’)) was performed on CD45+ immune cells, while single-cell RNA sequencing Flex (scRNA-seq (Flex)) and bulk RNA sequencing were conducted on unsorted cells. Additionally, an anti-TNFα antibody experiment was performed in a murine AS model induced by aortic valve wire injury. Results: In myeloid cells, LYVE1 resident macrophages were significantly decreased, whereas classical monocytes expressing pro-inflammatory genes and C1Q macrophages were increased in AS valves compared to AR valves. These macrophages exhibited strong interactions with valve interstitial cells, particularly with chondrogenic subtypes expressing COMP and SPARC. Anti-TNFα treatment in the murine model significantly reduced aortic valve calcification without hematopoietic complications. Conclusions: This study is the first to integrate scRNA-seq (3’) and scRNA-seq (Flex) analyses of human aortic valves, revealing single cell-level characteristics of immune cells and their interactions with non-immune cells in calcific AS. These findings suggest that anti-inflammatory therapy could be a therapeutic target for calcific AS.
- 🔗 查看原文
💡 该来源还有 732 条内容,详见 文末
🧪 博客更新 (3条)
详细内容(全部3条)
1. Ozempic 和 Wegovy 片剂中的隐藏成分引发了新的肠道健康问题
- ✍️ 作者:未知作者
- 🏷️ 关键词:gut、regex:gut(-?microbiome)?
- 📝 描述:Scientists are taking a closer look at the pill forms of Wegovy and Ozempic. In an animal study, the ingredient SNAC, which helps semaglutide survive the stomach and enter the bloodstream, was associated with changes in gut bacteria, inflammation markers, and a brain linked protein. The research does not show harm in people, but it raises new questions about the long term effects of daily exposure.
- 🔗 查看原文
2. 科学家发现细菌“自杀开关”,或将改变对抗超级细菌的斗争。
- ✍️ 作者:未知作者
- 🏷️ 关键词:regex:bacter(ia|ial|ium)
- 📝 描述:Drug-resistant bacteria are becoming harder to treat, pushing scientists to look for new antibiotic targets. Researchers have now discovered that several unrelated viruses disable a key bacterial protein called MurJ, which is essential for building the bacterial cell wall. High-resolution imaging shows these viral proteins lock MurJ into a single position, stopping cell wall construction and leading to bacterial death.
- 🔗 查看原文
3. 你早晨喝的咖啡或许有一天能帮助对抗癌症。
- ✍️ 作者:未知作者
- 🏷️ 关键词:cancer
- 📝 描述:Scientists at Texas A&M are turning an everyday pick-me-up into a high-tech medical switch. By combining caffeine with CRISPR gene editing, researchers have created a system that allows cells to be programmed in advance — and then activated simply by consuming a small dose of caffeine from coffee, chocolate, or soda. The approach, known as chemogenetics, lets scientists precisely turn gene-editing activity on and off inside targeted cells, including powerful immune T cells that can fight cancer.
- 🔗 查看原文
📊 关键词统计
| 关键词 | 出现次数 |
|---|---|
| T cell | 375 |
| scRNA | 78 |
| macrophage | 72 |
| RNA-seq | 52 |
| monocyte | 33 |
| carcinoma | 26 |
| B cell | 22 |
| sequencing | 18 |
| cancer | 15 |
| ATAC-seq | 11 |
| immune | 10 |
| lymph | 9 |
| regex:lymph(o | atic)? |
| leukemia | 8 |
| single-cell | 7 |
| cardiac | 6 |
| immunity | 6 |
| transcriptome | 5 |
| ChIP-seq | 5 |
| metabolic | 5 |
📎 更多内容
🧬 数据前沿 其他内容 (732条)
- GSE290864 同种异体造血干细胞移植后免疫细胞测序 [scRNA-seq]
- GSE245061 肿瘤相关高内皮静脉通过 ALOX12 驱动淋巴结门静脉特异性免疫逃逸 [III]
- GSE217454 肿瘤相关高内皮静脉通过ALOX12驱动淋巴结门静脉特异性免疫逃逸
- GSE217453 肿瘤相关高内皮静脉通过 ALOX12 驱动淋巴结门静脉特异性免疫逃逸 [II]
- GSE216939 肿瘤相关高内皮静脉通过 ALOX12 驱动淋巴结门静脉特异性免疫逃逸 [I]
- GSE322394 调节性 T 细胞 (ENCSR586TYE) 的总 RNA 测序
- GSE322036 PRO-cap from bronchial lymph node (ENCSR266TET)
- GSE321613 total RNA-seq from regulatory T cell (ENCSR980GQZ)
- GSE321582 total RNA-seq from regulatory T cell (ENCSR965WUE)
- GSE321371 ATAC-seq from regulatory T cell (ENCSR844TIU)
- GSE321310 total RNA-seq from regulatory T cell (ENCSR806BUK)
- GSE321170 total RNA-seq from regulatory T cell (ENCSR720CUD)
- GSE321076 total RNA-seq from regulatory T cell (ENCSR687HLO)
- GSE320925 PRO-cap from pulmonary lymph node (ENCSR633OWM)
- GSE320826 PRO-cap from colic lymph node (ENCSR122BHP)
- GSE320787 PRO-cap from paraaortic lymph node (ENCSR100PNA)
- GSE320761 total RNA-seq from regulatory T cell (ENCSR086CAL)
- GSE317486 Identification of CD74-positive antigen presenting glioma cells in primary human tumors and murine models of NF1 high-grade glioma
- GSE320275 microRNA-21促进脂质代谢紊乱和肝细胞癌
- GSE294887 针对不同前列腺癌细胞、经 LGK974、ENZ、EPZ6438、EED226 治疗的肿瘤或经 CTNNB1 基因敲低和过表达以及 BRN2 基因敲低处理的肿瘤的个体 RNA 测序数据
- GSE318386 scATAC测序数据,包括硬膜下、硬膜CAMs和MG在细胞再生后8周的情况
- GSE317606 帕博利珠单抗联合粒细胞巨噬细胞集落刺激因子治疗晚期胆道癌的II期临床试验
- GSE317605 帕博利珠单抗联合粒细胞巨噬细胞集落刺激因子治疗晚期胆道癌的 II 期试验 [CITE-Seq]
- GSE315520 circASCOR 增强卵巢癌的铂类耐药性
- GSE313584 DDX18 增强卵巢癌的铂类耐药性
- GSE312428 研究表明,油茶粉肽通过 AMPK/ACC/CPT-1 通路调节脂质代谢,从而缓解动脉粥样硬化。
- GSE312017 FOXA1/SPDEF 共调控轴通过驱动 ERBB2 表达和抑制 TEAD/YAP 驱动的 EMT 程序来维持 HER2 阳性乳腺癌的管腔特性 [RNA-Seq]
- GSE312016 FOXA1/SPDEF 共调控轴通过驱动 ERBB2 表达和抑制 TEAD/YAP 驱动的 EMT 程序来维持 HER2 阳性乳腺癌的管腔特性 [ATAC-seq]
- GSE311996 动力学测序能够对体内单细胞 RNA 动力学进行全面分析,从而揭示动态肿瘤异质性
- GSE311933 利用人类 CRISPR 工程 MLL 重排白血病模型表征 MLL 融合变体和融合伴侣对白血病可塑性的影响 [RNA-Seq Classical]
- GSE295518 synNotch CAR-巨噬细胞通过增强适应性免疫促进持久的抗肿瘤活性[scRNA-Seq 人类]
- GSE295335 脑膜/血管周围绒毛尿囊膜细胞 (CAM) 再植后 8 周的 RNA 测序数据。[scRNA-Seq]
- GSE294490 synNotch CAR-巨噬细胞通过增强适应性免疫促进持久的抗肿瘤活性[scRNA-Seq]
- GSE293014 利用单细胞RNA测序鉴定骨髓增生异常综合征中的克隆
- GSE291968 水稻抗EMS诱导细菌性枯萎病品系的转录组学分析
- GSE290836 同种异体造血干细胞移植后的免疫细胞测序
- GSE288802 飞秒激光微槽结合 CGF 通过 Smad3/JunD/TIMP-1 通路及其免疫调节机制促进种植体经龈整合
- GSE287527 Mek1和Mek2缺失对脾脏B细胞亚群转录组的影响
- GSE284820 棒状杆菌介导的抑制金黄色葡萄球菌诱导的慢性鼻窦炎上皮屏障损伤和炎症激活的机制[RNA-Seq]
- GSE282501 癌症相关同义突变选择性地靶向 p53 DNA 损伤反应 [ChIP-seq]
- GSE282500 癌症相关同义突变选择性地靶向 p53 DNA 损伤反应 [RNA-seq]
- GSE261683 研究KCP在介导宫颈鳞状细胞癌紫杉醇耐药性中的功能和机制
- GSE260843 细胞因子补充影响牛胚胎着床前转录组
- GSE230457 代谢性神经病小鼠背根神经节组织的RNA测序
- GSE227081 通过单细胞 RNA 测序揭示急性移植物抗宿主病 (GVHD) 发作时中性粒细胞的细胞异质性和起源
- GSE225491 H3-K27M 和 PDGFRA 之间的协同作用给人类 iPSC 衍生的弥漫性中线胶质瘤模型带来了多种治疗弱点(RNA-Seq)
- GSE293576 Partial truncation of the C-terminal domain of PTCH1 in cancer promotes tumorigenesis by non-canonical activation of GLI transcriptional activity.
- GSE322466 肾上腺长读长单细胞RNA测序 (ENCSR399GDY)
- GSE322465 海马层长读长单细胞RNA测序 (ENCSR398ZEK)
- GSE322455 CD4阳性、CD25阳性、αβ调节性T细胞(ENCSR389VFA)的DNase-seq
- GSE322454 抑制性巨噬细胞 (ENCSR389MPM) 的 DNase-seq
- GSE322452 CD4阳性αβ T细胞的DNase-seq (ENCSR387WVY)
- GSE322445 刺激活化的幼稚 CD4 阳性 αβ T 细胞 (ENCSR384YHO) 的 DNase-seq
- GSE322444 CD4阳性αβ T细胞的DNase-seq (ENCSR384XZK)
- GSE322441 肾上腺长读长单细胞RNA测序 (ENCSR382FLX)
- GSE322440 CD4阳性αβ T细胞的DNase-seq (ENCSR382DPL)
- GSE322439 CD4阳性αβ T细胞(ENCSR381PYB)的DNase-seq
- GSE322435 刺激活化的 CD4 阳性 αβ T 细胞 (ENCSR380XNG) 的 DNase-seq
- GSE322432 活化的 CD4 阳性、CD25 阳性、αβ 调节性 T 细胞 (ENCSR379LON) 的 DNase-seq
- GSE322425 抑制性巨噬细胞 (ENCSR377SES) 的 DNase-seq
- GSE322423 肾上腺长读长单细胞RNA测序 (ENCSR598DOS)
- GSE322420 海马层长读长单细胞RNA测序 (ENCSR596GDP)
- GSE322419 活化 CD4 阳性 αβ T 细胞的 DNase-seq (ENCSR595VTN)
- GSE322416 活化的 CD8 阳性 αβ 记忆 T 细胞 (ENCSR595BVP) 的 DNase-seq
- GSE322415 CD14阳性单核细胞的DNase-seq (ENCSR376UDG)
- GSE322413 细胞毒性 T 细胞的 PRO-cap (ENCSR594WJV)
- GSE322412 抑制性巨噬细胞的 DNase-seq (ENCSR593ZPX)
- GSE322409 CD4阳性αβ T细胞的DNase-seq (ENCSR375GZY)
- GSE322405 刺激活化的 CD4 阳性 αβ T 细胞的 DNase-seq (ENCSR591ZIA)
- GSE322402 炎症巨噬细胞的 DNase-seq (ENCSR372AMW)
- GSE322397 CD4阳性αβ T细胞的DNase-seq (ENCSR370SDS)
- GSE322395 活化的幼稚 CD4 阳性 αβ T 细胞的 DNase-seq (ENCSR588SBG)
- GSE322391 刺激活化的 CD4 阳性 αβ T 细胞的 DNase-seq (ENCSR368MTT)
- GSE322383 CD4阳性αβ T细胞(ENCSR581EVP)的DNase-seq
- GSE322377 CD14阳性单核细胞(ENCSR364YDG)的DNase-seq
- GSE322376 效应记忆 CD4 阳性 αβ T 细胞的 DNase-seq (ENCSR580MXV)
- GSE322372 CD4阳性αβ T细胞的DNase-seq (ENCSR579VQJ)
- GSE322369 活化的幼稚 CD4 阳性 αβ T 细胞的 DNase-seq (ENCSR578YFZ)
- GSE322365 肾上腺长读长单细胞RNA测序 (ENCSR578XKS)
- GSE322362 T辅助细胞2型总RNA测序(ENCSR578RIQ)
- GSE322360 活化 CD4 阳性 αβ T 细胞的 DNase-seq (ENCSR360STF)
- GSE322359 来自幼稚胸腺来源的 CD8 阳性 αβ T 细胞 (ENCSR577OFX) 的 DNase-seq
- GSE322350 脑转移性乳腺癌的 PRO-cap (ENCSR575EOB)
- GSE322347 海马层长读长单细胞RNA测序 (ENCSR355VSY)
- GSE322344 CD4阳性αβ T细胞(ENCSR574WTK)的DNase-seq
- GSE322341 抑制性巨噬细胞 (ENCSR354GEV) 的 DNase-seq
- GSE322334 T细胞总RNA测序(ENCSR351WPZ)
- GSE322326 抑制性巨噬细胞的 DNase-seq (ENCSR348JIL)
- GSE322322 刺激活化的 CD4 阳性 αβ T 细胞的 DNase-seq (ENCSR348EZO)
- GSE322320 炎症巨噬细胞的 DNase-seq (ENCSR571EXD)
- GSE322319 炎症巨噬细胞的 DNase-seq (ENCSR570VVF)
- GSE322315 刺激活化的 CD4 阳性 αβ T 细胞的 DNase-seq (ENCSR346UXU)
- GSE322310 活化效应记忆 CD4 阳性 αβ T 细胞 (ENCSR346KOV) 的 DNase-seq
- GSE322308 活化的 CD8 阳性 αβ 记忆 T 细胞的 DNase-seq (ENCSR564RTW)
- GSE322306 刺激活化的 CD4 阳性 αβ T 细胞的 DNase-seq (ENCSR344RFB)
- GSE322304 CD14阳性单核细胞(ENCSR343TXL)的DNase-seq
- GSE322295 来自幼稚胸腺来源的 CD8 阳性 αβ T 细胞 (ENCSR562TLN) 的 DNase-seq
- GSE322293 刺激活化的 CD4 阳性 αβ T 细胞的 DNase-seq (ENCSR561QYI)
- GSE322289 CD4阳性αβ T细胞(ENCSR336MXG)的DNase-seq
- GSE322280 CD4阳性αβ T细胞(ENCSR333NUA)的DNase-seq
- GSE322275 肺转移性结肠癌的 PRO-cap (ENCSR331QXJ)
- GSE322272 CD4阳性αβ T细胞的DNase-seq (ENCSR556EKY)
- GSE322266 T辅助细胞2型总RNA测序(ENCSR552NZO)
- GSE322264 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR327TKJ)
- GSE322261 DNase-seq from suppressor macrophage (ENCSR551PUD)
- GSE322260 DNase-seq from stimulated activated naive CD4-positive, alpha-beta T cell (ENCSR326UAU)
- GSE322257 ATAC-seq from T-helper 2 cell (ENCSR550NOH)
- GSE322253 long read scRNA-seq from layer of hippocampus (ENCSR325RRB)
- GSE322250 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR325CHP)
- GSE322249 DNase-seq from suppressor macrophage (ENCSR550BBN)
- GSE322241 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR548GMZ)
- GSE322238 DNase-seq from activated B cell (ENCSR320ICS)
- GSE322235 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR547RAS)
- GSE322233 DNase-seq from dendritic cell (ENCSR546QFM)
- GSE322223 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR541SYG)
- GSE322221 DNase-seq from activated naive CD4-positive, alpha-beta T cell (ENCSR316DUO)
- GSE322220 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR315ASD)
- GSE322218 total RNA-seq from T-helper 1 cell (ENCSR314LMX)
- GSE322217 DNase-seq from CD14-positive monocyte (ENCSR539ZYY)
- GSE322215 DNase-seq from stimulated activated naive CD4-positive, alpha-beta T cell (ENCSR537SRE)
- GSE322213 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR536XRT)
- GSE322210 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR535XEZ)
- GSE322196 DNase-seq from effector memory CD4-positive, alpha-beta T cell (ENCSR306NPY)
- GSE322184 DNase-seq from stimulated activated naive CD4-positive, alpha-beta T cell (ENCSR301LKN)
- GSE322181 PRO-cap from helper T cell (ENCSR528FMA)
- GSE322179 DNase-seq from activated B cell (ENCSR527ZIM)
- GSE322176 PRO-cap from Metastatic Liver Carcinoma in the Adrenal Gland (ENCSR300AAD)
- GSE322172 long read scRNA-seq from layer of hippocampus (ENCSR299OFL)
- GSE322163 long read scRNA-seq from layer of hippocampus (ENCSR297ZAZ)
- GSE322159 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR297CAE)
- GSE322145 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR293UHG)
- GSE322143 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR292ZPF)
- GSE322141 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR521EVK)
- GSE322137 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR518ZID)
- GSE322136 DNase-seq from inflammatory macrophage (ENCSR291PNO)
- GSE322134 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR290TTN)
- GSE322127 DNase-seq from CD14-positive monocyte (ENCSR288RCG)
- GSE322120 total RNA-seq from T-cell (ENCSR515KJR)
- GSE322119 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR287XTD)
- GSE322118 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR287XKF)
- GSE322114 ATAC-seq from T-cell (ENCSR285REQ)
- GSE322109 total RNA-seq from T-cell (ENCSR283CSY)
- GSE322108 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR514OPX)
- GSE322107 DNase-seq from CD14-positive monocyte (ENCSR514NZF)
- GSE322101 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR513LOX)
- GSE322100 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR511ZQB)
- GSE322098 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR282DYY)
- GSE322094 DNase-seq from inflammatory macrophage (ENCSR280URP)
- GSE322092 DNase-seq from activated effector memory CD4-positive, alpha-beta T cell (ENCSR510LEO)
- GSE322087 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR279NGE)
- GSE322081 DNase-seq from suppressor macrophage (ENCSR508WDL)
- GSE322079 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR508PBU)
- GSE322075 DNase-seq from naive B cell (ENCSR505SCQ)
- GSE322072 DNase-seq from naive thymus-derived CD8-positive, alpha-beta T cell (ENCSR505APK)
- GSE322071 DNase-seq from activated CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR276MBW)
- GSE322067 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR501QAE)
- GSE322064 DNase-seq from CD14-positive monocyte (ENCSR500ZQD)
- GSE322062 DNase-seq from activated effector memory CD4-positive, alpha-beta T cell (ENCSR274HUK)
- GSE322059 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR500LKJ)
- GSE322056 DNase-seq from suppressor macrophage (ENCSR271PQC)
- GSE322055 DNase-seq from B cell (ENCSR500IJD)
- GSE322053 PRO-cap from left cardiac atrium (ENCSR270EGA)
- GSE322045 total RNA-seq from T-helper 2 cell (ENCSR498SYM)
- GSE322042 long read scRNA-seq from adrenal gland (ENCSR497PUD)
- GSE322041 ATAC-seq from T-helper 1 cell (ENCSR497DZG)
- GSE322040 DNase-seq from activated CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR267DTS)
- GSE322037 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR496NUW)
- GSE322035 DNase-seq from activated B cell (ENCSR266PJC)
- GSE322034 total RNA-seq from T-helper 17 cell (ENCSR496AHR)
- GSE322032 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR266MTD)
- GSE322031 long read scRNA-seq from layer of hippocampus (ENCSR492SHL)
- GSE322029 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR266MPT)
- GSE322028 DNase-seq from suppressor macrophage (ENCSR491ORH)
- GSE322027 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR266IUC)
- GSE322026 DNase-seq from CD14-positive monocyte (ENCSR491DPW)
- GSE322024 long read scRNA-seq from layer of hippocampus (ENCSR265JEM)
- GSE322015 DNase-seq from suppressor macrophage (ENCSR489GKS)
- GSE322011 DNase-seq from effector memory CD4-positive, alpha-beta T cell (ENCSR262CJS)
- GSE322007 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR261HXP)
- GSE322006 long read scRNA-seq from adrenal gland (ENCSR260YIQ)
- GSE322005 DNase-seq from activated gamma-delta T cell (ENCSR260SDO)
- GSE322003 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR259YKO)
- GSE322001 DNase-seq from suppressor macrophage (ENCSR485ZRK)
- GSE321998 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR485OYS)
- GSE321995 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR258TNJ)
- GSE321994 DNase-seq from activated B cell (ENCSR484IKU)
- GSE321991 PRO-cap from cardiac septum (ENCSR484CAZ)
- GSE321990 DNase-seq from effector CD4-positive, alpha-beta T cell (ENCSR256URJ)
- GSE321989 long read scRNA-seq from layer of hippocampus (ENCSR483UXN)
- GSE321988 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR483FNY)
- GSE321986 DNase-seq from right cardiac atrium (ENCSR256KBZ)
- GSE321977 DNase-seq from inflammatory macrophage (ENCSR255JWJ)
- GSE321966 DNase-seq from CD14-positive monocyte (ENCSR476KXY)
- GSE321965 DNase-seq from inflammatory macrophage (ENCSR254QMG)
- GSE321960 long read scRNA-seq from layer of hippocampus (ENCSR253UOM)
- GSE321957 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR472QAJ)
- GSE321955 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR252WDE)
- GSE321954 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR252QDU)
- GSE321952 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR252HYG)
- GSE321951 long read scRNA-seq from layer of hippocampus (ENCSR472AKY)
- GSE321950 long read scRNA-seq from adrenal gland (ENCSR252DYO)
- GSE321949 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR471QHJ)
- GSE321940 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR469VWD)
- GSE321938 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR469JAF)
- GSE321936 total RNA-seq from T-helper 17 cell (ENCSR467PMU)
- GSE321935 DNase-seq from activated CD8-positive, alpha-beta T cell (ENCSR467EZY)
- GSE321934 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR466VMM)
- GSE321929 long read scRNA-seq from layer of hippocampus (ENCSR465BRP)
- GSE321928 perturbation followed by scRNA-seq from K562 (ENCSR464SPV)
- GSE321915 long read scRNA-seq from layer of hippocampus (ENCSR245GNB)
- GSE321912 DNase-seq from suppressor macrophage (ENCSR458QPA)
- GSE321911 total RNA-seq from T-helper 2 cell (ENCSR243YLR)
- GSE321905 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR455ERT)
- GSE321901 DNase-seq from inflammatory macrophage (ENCSR452KBX)
- GSE321900 DNase-seq from suppressor macrophage (ENCSR240YST)
- GSE321898 long read scRNA-seq from layer of hippocampus (ENCSR240WAO)
- GSE321896 DNase-seq from suppressor macrophage (ENCSR451VKL)
- GSE321895 long read scRNA-seq from adrenal gland (ENCSR239HYJ)
- GSE321894 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR239DGJ)
- GSE321893 DNase-seq from CD14-positive monocyte (ENCSR451UAB)
- GSE321890 DNase-seq from activated B cell (ENCSR450TJS)
- GSE321885 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR238EXW)
- GSE321883 DNase-seq from naive thymus-derived CD8-positive, alpha-beta T cell (ENCSR450JEN)
- GSE321881 long read scRNA-seq from layer of hippocampus (ENCSR449BGI)
- GSE321876 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR236SNH)
- GSE321870 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR233JAE)
- GSE321867 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR446WYO)
- GSE321866 long read scRNA-seq from layer of hippocampus (ENCSR232UUS)
- GSE321864 DNase-seq from activated CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR230TXS)
- GSE321861 DNase-seq from effector CD4-positive, alpha-beta T cell (ENCSR230EOI)
- GSE321854 DNase-seq from CD14-positive monocyte (ENCSR229QWH)
- GSE321852 DNase-seq from suppressor macrophage (ENCSR229PWD)
- GSE321851 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR443MTJ)
- GSE321849 DNase-seq from inflammatory macrophage (ENCSR229PJJ)
- GSE321847 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR442NTT)
- GSE321846 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR229MWU)
- GSE321842 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR441AZV)
- GSE321840 DNase-seq from activated B cell (ENCSR439ZKZ)
- GSE321839 total RNA-seq from T-helper 1 cell (ENCSR439QXU)
- GSE321837 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR228MIG)
- GSE321834 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR437XJH)
- GSE321830 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR228KFJ)
- GSE321829 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR437GGZ)
- GSE321827 PRO-cap from Metastatic Breast Carcinoma in the Brain (ENCSR436JXW)
- GSE321822 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR226WID)
- GSE321820 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR434MLE)
- GSE321812 DNase-seq from CD14-positive monocyte (ENCSR223HHH)
- GSE321808 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR432IUH)
- GSE321806 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR431YXV)
- GSE321800 long read scRNA-seq from adrenal gland (ENCSR431FYK)
- GSE321797 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR431AMA)
- GSE321791 DNase-seq from inflammatory macrophage (ENCSR429YWF)
- GSE321787 PRO-cap from Metastatic Breast Carcinoma in the Brain (ENCSR216FUJ)
- GSE321786 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR216AOU)
- GSE321779 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR215NSJ)
- GSE321777 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR215LLE)
- GSE321770 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR213VBE)
- GSE321768 DNase-seq from CD14-positive monocyte (ENCSR213GEE)
- GSE321767 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR213CHG)
- GSE321765 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR424HIL)
- GSE321761 long read scRNA-seq from adrenal gland (ENCSR423FFY)
- GSE321757 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR419WOC)
- GSE321752 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR211RMM)
- GSE321750 total RNA-seq from T-helper 2 cell (ENCSR211JWD)
- GSE321747 DNase-seq from B cell (ENCSR415DLI)
- GSE321738 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR410FVX)
- GSE321737 DNase-seq from activated B cell (ENCSR410APR)
- GSE321735 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR209HFQ)
- GSE321728 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR407IGM)
- GSE321724 long read scRNA-seq from layer of hippocampus (ENCSR405VKO)
- GSE321723 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR404FTK)
- GSE321719 DNase-seq from suppressor macrophage (ENCSR206KER)
- GSE321713 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR203NQT)
- GSE321709 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR402WYE)
- GSE321708 total RNA-seq from T-cell (ENCSR402EKP)
- GSE321703 FACS CRISPR screen from activated CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR202QXN)
- GSE321702 DNase-seq from CD14-positive monocyte (ENCSR201XLV)
- GSE321653 DNase-seq from inflammatory macrophage (ENCSR998XKB)
- GSE321646 DNase-seq from suppressor macrophage (ENCSR994OJO)
- GSE321645 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR992SOX)
- GSE321643 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR992GOJ)
- GSE321642 long read scRNA-seq from layer of hippocampus (ENCSR991UOI)
- GSE321640 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR991AXZ)
- GSE321639 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR990EYX)
- GSE321636 DNase-seq from inflammatory macrophage (ENCSR989RNC)
- GSE321635 DNase-seq from activated CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR988EYC)
- GSE321631 DNase-seq from CD4-positive, alpha-beta memory T cell (ENCSR986NEV)
- GSE321629 total RNA-seq from T-helper 2 cell (ENCSR986CSD)
- GSE321628 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR985PID)
- GSE321626 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR985FKG)
- GSE321625 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR984TLG)
- GSE321622 DNase-seq from suppressor macrophage (ENCSR983UJS)
- GSE321617 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR983DPK)
- GSE321616 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR982BNM)
- GSE321615 PRO-cap from Metastatic Breast Carcinoma in the Brain (ENCSR980TGS)
- GSE321612 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR979IWW)
- GSE321610 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR978KAK)
- GSE321607 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR977MYO)
- GSE321606 long read scRNA-seq from layer of hippocampus (ENCSR976OMS)
- GSE321604 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR976CAP)
- GSE321603 long read scRNA-seq from layer of hippocampus (ENCSR975GDE)
- GSE321601 DNase-seq from CD14-positive monocyte (ENCSR974QPL)
- GSE321598 total RNA-seq from T-helper 17 cell (ENCSR973CTO)
- GSE321597 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR972MPK)
- GSE321592 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR970HKQ)
- GSE321591 DNase-seq from inflammatory macrophage (ENCSR970HKH)
- GSE321588 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR968CBW)
- GSE321584 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR966NJV)
- GSE321578 long read scRNA-seq from layer of hippocampus (ENCSR962GMG)
- GSE321577 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR962BSK)
- GSE321576 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR961WRZ)
- GSE321571 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR957ATV)
- GSE321570 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR956PYO)
- GSE321569 DNase-seq from stimulated activated naive CD4-positive, alpha-beta T cell (ENCSR956ISH)
- GSE321568 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR956DYM)
- GSE321566 DNase-seq from CD14-positive monocyte (ENCSR956AOH)
- GSE321563 long read scRNA-seq from layer of hippocampus (ENCSR955GIF)
- GSE321561 total RNA-seq from T-helper 17 cell (ENCSR954LXW)
- GSE321546 DNase-seq from activated B cell (ENCSR947XQR)
- GSE321540 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR944FRU)
- GSE321538 DNase-seq from CD14-positive monocyte (ENCSR943WGU)
- GSE321537 DNase-seq from CD14-positive monocyte (ENCSR943TGB)
- GSE321531 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR940WCM)
- GSE321527 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR938ILX)
- GSE321522 PRO-cap from Metastatic Breast Carcinoma in the Ovary (ENCSR934ZMQ)
- GSE321519 DNase-seq from CD8-positive, alpha-beta memory T cell (ENCSR932FDJ)
- GSE321518 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR931GDW)
- GSE321517 DNase-seq from suppressor macrophage (ENCSR930UXG)
- GSE321512 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR926VLE)
- GSE321511 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR926QVW)
- GSE321504 DNase-seq from suppressor macrophage (ENCSR924DAW)
- GSE321503 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR922ZKR)
- GSE321502 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR922GGG)
- GSE321501 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR921CMS)
- GSE321499 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR918XFE)
- GSE321498 long read scRNA-seq from layer of hippocampus (ENCSR917FMK)
- GSE321496 DNase-seq from CD14-positive monocyte (ENCSR916HXX)
- GSE321492 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR915IJN)
- GSE321490 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR914WLK)
- GSE321488 DNase-seq from CD14-positive monocyte (ENCSR913VNJ)
- GSE321481 DNase-seq from CD4-positive, alpha-beta memory T cell (ENCSR909JZY)
- GSE321480 total RNA-seq from T-cell (ENCSR907YLF)
- GSE321477 DNase-seq from CD14-positive monocyte (ENCSR906STR)
- GSE321476 DNase-seq from inflammatory macrophage (ENCSR906FTC)
- GSE321475 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR905WMP)
- GSE321472 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR903KED)
- GSE321466 long read scRNA-seq from adrenal gland (ENCSR899YHN)
- GSE321464 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR898VHI)
- GSE321453 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR891QSP)
- GSE321450 DNase-seq from CD14-positive monocyte (ENCSR889CFS)
- GSE321448 PRO-cap from Metastatic Breast Carcinoma in the Brain (ENCSR888DKJ)
- GSE321447 DNase-seq from suppressor macrophage (ENCSR888CYN)
- GSE321445 PRO-cap from right cardiac atrium (ENCSR883PPD)
- GSE321436 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR878VDA)
- GSE321435 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR878QFU)
- GSE321433 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR877MQW)
- GSE321430 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR876NYG)
- GSE321429 PRO-cap from Metastatic Liver Carcinoma in the Adrenal Gland (ENCSR876AEQ)
- GSE321424 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR873VSJ)
- GSE321420 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR872SMV)
- GSE321419 DNase-seq from naive B cell (ENCSR871ZIX)
- GSE321418 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR870MGV)
- GSE321417 long read scRNA-seq from adrenal gland (ENCSR870HRG)
- GSE321414 DNase-seq from inflammatory macrophage (ENCSR866LHK)
- GSE321412 DNase-seq from central memory CD4-positive, alpha-beta T cell (ENCSR865TVC)
- GSE321406 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR862VUK)
- GSE321405 DNase-seq from CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR862SMY)
- GSE321404 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR862IXM)
- GSE321403 DNase-seq from inflammatory macrophage (ENCSR862FLW)
- GSE321401 long read scRNA-seq from layer of hippocampus (ENCSR860HBH)
- GSE321396 DNase-seq from activated naive CD4-positive, alpha-beta T cell (ENCSR856UND)
- GSE321393 long read scRNA-seq from layer of hippocampus (ENCSR854MEF)
- GSE321392 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR854HBF)
- GSE321391 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR851YCL)
- GSE321387 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR851DQZ)
- GSE321386 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR850JHZ)
- GSE321383 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR849MXJ)
- GSE321381 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR848VCF)
- GSE321378 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR846HUP)
- GSE321377 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR846BLW)
- GSE321373 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR845HOD)
- GSE321365 PRO-cap from monocyte (ENCSR841GXY)
- GSE321362 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR837WQM)
- GSE321361 DNase-seq from suppressor macrophage (ENCSR837KQM)
- GSE321355 DNase-seq from effector memory CD8-positive, alpha-beta T cell (ENCSR831ZGB)
- GSE321353 long read scRNA-seq from adrenal gland (ENCSR831BQT)
- GSE321352 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR830WDA)
- GSE321349 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR830BKZ)
- GSE321346 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR828DHC)
- GSE321345 DNase-seq from effector CD8-positive, alpha-beta T cell (ENCSR826AAY)
- GSE321344 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR825AHY)
- GSE321341 DNase-seq from activated effector memory CD4-positive, alpha-beta T cell (ENCSR823UQF)
- GSE321330 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR818QNO)
- GSE321328 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR817DXI)
- GSE321324 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR814VJU)
- GSE321321 PRO-cap from Metastatic Breast Carcinoma in the Brain (ENCSR813CRU)
- GSE321319 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR811DXO)
- GSE321318 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR811BXU)
- GSE321316 PRO-cap from Metastatic Breast Carcinoma in the Ovary (ENCSR810UBG)
- GSE321315 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR809QZB)
- GSE321314 DNase-seq from stimulated activated naive CD4-positive, alpha-beta T cell (ENCSR808LCB)
- GSE321309 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR804YMP)
- GSE321295 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR795FXU)
- GSE321294 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR794YNM)
- GSE321287 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR792NKI)
- GSE321285 DNase-seq from suppressor macrophage (ENCSR791JIS)
- GSE321284 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR789SDE)
- GSE321280 DNase-seq from CD4-positive, alpha-beta memory T cell (ENCSR783PRH)
- GSE321275 DNase-seq from CD14-positive monocyte (ENCSR781KKA)
- GSE321272 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR779CRB)
- GSE321267 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR773RLS)
- GSE321265 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR772GHU)
- GSE321263 long read scRNA-seq from adrenal gland (ENCSR770VEJ)
- GSE321258 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR767KPT)
- GSE321257 long read scRNA-seq from adrenal gland (ENCSR766SVW)
- GSE321252 DNase-seq from suppressor macrophage (ENCSR765EPO)
- GSE321250 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR764EVU)
- GSE321249 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR763VFD)
- GSE321248 STARR-seq from activated CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR763SPB)
- GSE321244 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR759IXC)
- GSE321243 DNase-seq from naive thymus-derived CD8-positive, alpha-beta T cell (ENCSR758RFT)
- GSE321241 DNase-seq from inflammatory macrophage (ENCSR756ZVZ)
- GSE321240 DNase-seq from CD4-positive, alpha-beta memory T cell (ENCSR756RES)
- GSE321239 DNase-seq from suppressor macrophage (ENCSR756KBW)
- GSE321235 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR753LFV)
- GSE321233 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR752AMS)
- GSE321232 total RNA-seq from T-helper 17 cell (ENCSR751OOH)
- GSE321231 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR751HTI)
- GSE321230 total RNA-seq from T-cell (ENCSR751BRT)
- GSE321229 long read scRNA-seq from adrenal gland (ENCSR750VIU)
- GSE321223 DNase-seq from activated CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR747VKR)
- GSE321222 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR747HAA)
- GSE321219 STARR-seq from activated naive CD4-positive, alpha-beta T cell (ENCSR744ZON)
- GSE321217 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR744SBK)
- GSE321214 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR744GUN)
- GSE321213 long read scRNA-seq from adrenal gland (ENCSR744DDC)
- GSE321212 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR743TBE)
- GSE321211 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR742TYK)
- GSE321210 DNase-seq from inflammatory macrophage (ENCSR741KNG)
- GSE321209 long read scRNA-seq from adrenal gland (ENCSR741JGK)
- GSE321206 DNase-seq from suppressor macrophage (ENCSR737KFS)
- GSE321200 DNase-seq from inflammatory macrophage (ENCSR735SMO)
- GSE321198 DNase-seq from inflammatory macrophage (ENCSR735HHO)
- GSE321194 DNase-seq from naive thymus-derived CD8-positive, alpha-beta T cell (ENCSR730VZO)
- GSE321191 DNase-seq from suppressor macrophage (ENCSR730ACX)
- GSE321190 DNase-seq from activated B cell (ENCSR729RAF)
- GSE321188 long read scRNA-seq from adrenal gland (ENCSR728BUZ)
- GSE321186 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR726ZEY)
- GSE321185 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR726XQP)
- GSE321184 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR726RYN)
- GSE321183 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR726KJM)
- GSE321182 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR725ZZX)
- GSE321181 DNase-seq from activated CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR725JPJ)
- GSE321180 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR724QRE)
- GSE321179 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR724OUB)
- GSE321177 DNase-seq from naive B cell (ENCSR723JLO)
- GSE321171 PRO-cap from Metastatic Liver Carcinoma in the Lung (ENCSR720EXP)
- GSE321168 DNase-seq from activated B cell (ENCSR719XDW)
- GSE321163 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR718UUG)
- GSE321162 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR718SCQ)
- GSE321161 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR718KCD)
- GSE321160 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR718CZL)
- GSE321156 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR715WRI)
- GSE321154 DNase-seq from inflammatory macrophage (ENCSR715DPJ)
- GSE321153 DNase-seq from inflammatory macrophage (ENCSR714TXO)
- GSE321151 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR713PIT)
- GSE321149 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR712GQL)
- GSE321148 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR712DRN)
- GSE321147 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR712CJF)
- GSE321146 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR711PYQ)
- GSE321137 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR197JOR)
- GSE321136 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR708HNS)
- GSE321135 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR708BGC)
- GSE321134 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR196PES)
- GSE321132 DNase-seq from activated B cell (ENCSR194PUL)
- GSE321129 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR194LBI)
- GSE321127 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR194IDR)
- GSE321126 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR704CZH)
- GSE321121 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR193CKS)
- GSE321120 DNase-seq from CD14-positive monocyte (ENCSR700VUT)
- GSE321117 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR191UKK)
- GSE321115 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR191ADB)
- GSE321113 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR190OQD)
- GSE321112 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR699FZG)
- GSE321111 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR698VCR)
- GSE321107 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR698MMQ)
- GSE321105 DNase-seq from stimulated activated naive CD4-positive, alpha-beta T cell (ENCSR188KVY)
- GSE321103 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR697VRN)
- GSE321102 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR187PYU)
- GSE321098 DNase-seq from suppressor macrophage (ENCSR694OIL)
- GSE321089 DNase-seq from inflammatory macrophage (ENCSR184EVK)
- GSE321086 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR690DEH)
- GSE321079 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR688KJW)
- GSE321078 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR182DLC)
- GSE321077 PRO-cap from Metastatic Breast Carcinoma in the Brain (ENCSR687HZX)
- GSE321073 DNase-seq from inflammatory macrophage (ENCSR687GAA)
- GSE321072 PRO-cap from Metastatic Breast Carcinoma in the Brain (ENCSR180NBV)
- GSE321068 DNase-seq from suppressor macrophage (ENCSR179UUK)
- GSE321066 DNase-seq from activated CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR179DAP)
- GSE321061 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR686FHJ)
- GSE321060 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR178XIU)
- GSE321059 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR178QSI)
- GSE321058 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR685ZOX)
- GSE321057 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR177UBF)
- GSE321052 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR685FKP)
- GSE321051 PRO-cap from Metastatic Pancreatic Carcinoma in the Ovary (ENCSR175VMO)
- GSE321047 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR684OCJ)
- GSE321044 PRO-cap from helper T cell (ENCSR683YVU)
- GSE321040 long read scRNA-seq from layer of hippocampus (ENCSR683IIF)
- GSE321038 DNase-seq from CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR172RHL)
- GSE321029 DNase-seq from suppressor macrophage (ENCSR679BYA)
- GSE321027 long read scRNA-seq from layer of hippocampus (ENCSR170VWE)
- GSE321024 DNase-seq from CD8-positive, alpha-beta memory T cell (ENCSR677CYJ)
- GSE321021 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR675FHK)
- GSE321020 total RNA-seq from T-helper 17 cell (ENCSR169MYZ)
- GSE321019 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR674LCO)
- GSE321017 long read scRNA-seq from layer of hippocampus (ENCSR674HUF)
- GSE321013 long read scRNA-seq from adrenal gland (ENCSR673ZVY)
- GSE321012 PRO-cap from Metastatic Lung Carcinoma in the Adrenal Gland (ENCSR673CJC)
- GSE321010 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR671PJK)
- GSE321006 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR670KEJ)
- GSE321004 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR670JXY)
- GSE320997 PRO-cap from Colon Carcinoma Metastatic in the Lung (ENCSR666GXV)
- GSE320996 DNase-seq from central memory CD8-positive, alpha-beta T cell (ENCSR665ZKM)
- GSE320993 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR664QPP)
- GSE320992 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR664DPC)
- GSE320986 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR164QVW)
- GSE320985 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR164OGQ)
- GSE320984 DNase-seq from effector memory CD8-positive, alpha-beta T cell (ENCSR162NNR)
- GSE320965 DNase-seq from activated B cell (ENCSR653JLD)
- GSE320958 DNase-seq from naive thymus-derived CD8-positive, alpha-beta T cell (ENCSR650FUK)
- GSE320956 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR647XBL)
- GSE320954 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR647HGY)
- GSE320953 PRO-cap from Colon Carcinoma Metastatic in the Brain (ENCSR644TYW)
- GSE320952 DNase-seq from activated B cell (ENCSR642YPV)
- GSE320949 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR642FCN)
- GSE320948 long read scRNA-seq from adrenal gland (ENCSR641RYW)
- GSE320943 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR640KVD)
- GSE320942 ATAC-seq from T-helper 17 cell (ENCSR639PPN)
- GSE320941 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR639HIL)
- GSE320934 long read scRNA-seq from layer of hippocampus (ENCSR637ORL)
- GSE320933 DNase-seq from inflammatory macrophage (ENCSR637ELM)
- GSE320929 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR635SLV)
- GSE320918 DNase-seq from CD14-positive monocyte (ENCSR629GFF)
- GSE320917 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR629CES)
- GSE320916 long read scRNA-seq from adrenal gland (ENCSR628CKI)
- GSE320903 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR617VJH)
- GSE320902 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR160AWN)
- GSE320901 PRO-cap from Metastatic Breast Carcinoma in the Ovary (ENCSR617JRP)
- GSE320900 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR616BQA)
- GSE320899 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR616AQJ)
- GSE320897 long read scRNA-seq from layer of hippocampus (ENCSR157ZUT)
- GSE320891 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR156DZX)
- GSE320890 PRO-cap from Metastatic Breast Carcinoma in the Brain (ENCSR610POV)
- GSE320887 DNase-seq from CD14-positive monocyte (ENCSR609PYW)
- GSE320878 long read scRNA-seq from adrenal gland (ENCSR604HPH)
- GSE320877 long read scRNA-seq from layer of hippocampus (ENCSR604GLK)
- GSE320875 DNase-seq from activated CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR151UPI)
- GSE320872 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR601QTE)
- GSE320871 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR151MUX)
- GSE320868 DNase-seq from CD14-positive monocyte (ENCSR601HWV)
- GSE320866 total RNA-seq from T-helper 1 cell (ENCSR600QUH)
- GSE320865 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR600PWZ)
- GSE320864 PRO-cap from Metastatic Liver Carcinoma in the Lung (ENCSR149WMX)
- GSE320861 DNase-seq from activated CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR146FHV)
- GSE320859 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR144JQL)
- GSE320857 total RNA-seq from T-helper 1 cell (ENCSR141PRV)
- GSE320855 DNase-seq from activated naive CD4-positive, alpha-beta T cell (ENCSR140EQO)
- GSE320852 DNase-seq from activated B cell (ENCSR138FUS)
- GSE320849 long read scRNA-seq from layer of hippocampus (ENCSR137PNB)
- GSE320846 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR136JHK)
- GSE320845 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR136EXX)
- GSE320835 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR130SOU)
- GSE320821 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR118HJI)
- GSE320816 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR117HIN)
- GSE320814 DNase-seq from CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR116MMP)
- GSE320808 DNase-seq from inflammatory macrophage (ENCSR111MLU)
- GSE320806 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR110WYZ)
- GSE320803 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR108LRW)
- GSE320801 DNase-seq from inflammatory macrophage (ENCSR105BTM)
- GSE320798 DNase-seq from CD14-positive monocyte (ENCSR103ZWK)
- GSE320792 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR102GSP)
- GSE320789 DNase-seq from CD14-positive monocyte (ENCSR101KYT)
- GSE320788 total RNA-seq from T-helper 2 cell (ENCSR100YQC)
- GSE320785 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR098YWP)
- GSE320778 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR095GDO)
- GSE320776 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR094EAF)
- GSE320774 PRO-cap from monocyte (ENCSR093JST)
- GSE320773 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR093BGQ)
- GSE320772 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR092JBF)
- GSE320770 DNase-seq from activated CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR090JIM)
- GSE320766 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR088JFQ)
- GSE320759 DNase-seq from CD14-positive monocyte (ENCSR083DZB)
- GSE320758 PRO-cap from B cell (ENCSR083AMN)
- GSE320750 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR079MZU)
- GSE320746 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR076OSM)
- GSE320745 total RNA-seq from T-helper 1 cell (ENCSR076CCA)
- GSE320744 PRO-cap from Colon Carcinoma Metastatic in the Brain (ENCSR074XYR)
- GSE320743 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR074UOT)
- GSE320741 DNase-seq from activated CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR073PJU)
- GSE320740 total RNA-seq from T-helper 1 cell (ENCSR073FPO)
- GSE320739 DNase-seq from CD14-positive monocyte (ENCSR073CPU)
- GSE320735 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR071ZVJ)
- GSE320733 DNase-seq from CD8-positive, alpha-beta memory T cell (ENCSR071CAW)
- GSE320730 PRO-cap from cytotoxic T cell (ENCSR069DQH)
- GSE320729 long read scRNA-seq from layer of hippocampus (ENCSR068XEK)
- GSE320727 DNase-seq from activated CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR067MLO)
- GSE320726 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR066BYY)
- GSE320725 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR066ARN)
- GSE320717 long read scRNA-seq from adrenal gland (ENCSR062QQH)
- GSE320716 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR062EZB)
- GSE320714 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR061LMN)
- GSE320711 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR060YHM)
- GSE320704 DNase-seq from activated CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR056UNT)
- GSE320695 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR053DYH)
- GSE320692 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR051UEN)
- GSE320689 DNase-seq from activated naive CD4-positive, alpha-beta T cell (ENCSR049EWR)
- GSE320685 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR047OET)
- GSE320683 DNase-seq from activated CD8-positive, alpha-beta memory T cell (ENCSR046CHZ)
- GSE320680 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR045NQF)
- GSE320678 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR044QVE)
- GSE320677 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR043OPR)
- GSE320676 DNase-seq from cardiac muscle cell (ENCSR041RRW)
- GSE320674 DNase-seq from activated CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR040VOK)
- GSE320673 DNase-seq from B cell (ENCSR040SOG)
- GSE320669 DNase-seq from suppressor macrophage (ENCSR038TGY)
- GSE320667 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR038NGR)
- GSE320666 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR036ZBI)
- GSE320664 DNase-seq from CD4-positive, CD25-positive, alpha-beta regulatory T cell (ENCSR036REG)
- GSE320662 total RNA-seq from T-cell (ENCSR036EDO)
- GSE320656 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR032SJX)
- GSE320653 DNase-seq from suppressor macrophage (ENCSR031CYX)
- GSE320652 DNase-seq from suppressor macrophage (ENCSR030ZGP)
- GSE320651 long read scRNA-seq from adrenal gland (ENCSR030XVR)
- GSE320650 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR029QFS)
- GSE320648 DNase-seq from inflammatory macrophage (ENCSR029DUS)
- GSE320646 long read scRNA-seq from adrenal gland (ENCSR027HXJ)
- GSE320645 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR026VVD)
- GSE320642 DNase-seq from inflammatory macrophage (ENCSR023BJE)
- GSE320639 DNase-seq from inflammatory macrophage (ENCSR019QLA)
- GSE320632 long read scRNA-seq from adrenal gland (ENCSR016VQS)
- GSE320631 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR016IMD)
- GSE320623 DNase-seq from activated CD4-positive, alpha-beta T cell (ENCSR012LNE)
- GSE320622 DNase-seq from stimulated activated CD4-positive, alpha-beta T cell (ENCSR011KKH)
- GSE320621 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR011COH)
- GSE320617 DNase-seq from inflammatory macrophage (ENCSR009WGS)
- GSE320616 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR009UTO)
- GSE320615 DNase-seq from left cardiac atrium (ENCSR009OHB)
- GSE320614 DNase-seq from CD4-positive, alpha-beta T cell (ENCSR009BPM)
- GSE320612 PRO-cap from Metastatic Breast Carcinoma in the Brain (ENCSR008TSD)
- GSE320605 DNase-seq from CD8-positive, alpha-beta T cell (ENCSR003CJK)
- GSE320146 total RNA-seq from T-helper 17 cell (ENCSR000YRX)
- GSE320145 long read scRNA-seq from adrenal gland (ENCSR000GUP)
- GSE319275 单细胞转录组分析揭示了慢性脑低灌注引起的血管生成反应。
- GSE309502 拟南芥避荫反应中 N6-甲基腺苷的转录组范围分析
- GSE294966 针对β-catenin、EZH2、EED、KMT2B、H3K4me3、H3K27me3 和序列芯片测序的 ChIP-seq
- GSE320363 温度和发育阶段决定肠道对人类冠状病毒 229E 的易感性。
- GSE320024 二甲双胍诱导的长寿与酵母时间衰老过程中的逆转录转座子动态有关
- GSE319662 BCL6B通过转录抑制GGT5和调节MAPK信号通路来抑制急性髓系白血病进展
- GSE319492 miR-15b 和 miR-16-2 过表达对人类 T 细胞急性淋巴细胞白血病 (T-ALL) 细胞系 CUTLL1 基因表达谱的影响。
- GSE318348 Npm1cA/Flt3-ITD急性髓系白血病干细胞的单细胞LARRY状态-命运分析
- GSE318159 RNA测序数据,用于追踪脑膜/血管周围细胞黏附分子(CAMs)在细胞增殖后8周和MCAo后1天的命运变化。
- GSE318071 RNA测序数据,用于研究LPS刺激后8周硬脑膜绒毛尿囊膜细胞再生的情况。
- GSE317967 急性髓系白血病患者和健康供者的骨髓RNA测序谱
- GSE314594 冷冻热疗法可将髓系细胞重编程为 CCL5+ 成熟表型,从而增加 T 细胞浸润并增强抗 PD-1 疗法的效果
- GSE313041 α-突触核蛋白转基因小鼠对高脂饮食的表观遗传适应性丧失
- GSE312263 Mtr-cKO 和野生型小鼠海马的简化代表性亚硫酸氢盐测序 (RRBS)
- GSE311762 SLIT家族在不同脑区中的差异表达分析
- GSE311674 利用人源 CRISPR 工程化 MLL 重排白血病模型表征 MLL 融合变异体和融合伴侣对白血病可塑性的影响
- GSE308039 AID 在弥漫性大 B 细胞淋巴瘤中协调 MYC/E2F 靶基因激活和细胞起源转录程序 [GCB_AID-ER_RNA-seq]
- GSE308038 AID 在弥漫性大 B 细胞淋巴瘤中协调 MYC/E2F 靶基因激活和细胞起源转录程序 [ABC_AID-ER_RNA-seq]
- GSE308037 AID 在弥漫性大 B 细胞淋巴瘤中协调 MYC/E2F 靶基因激活和细胞起源转录程序 [ABC_AID_KO_RNA-seq]
- GSE307110 IL-36γ 装甲 CAR T 细胞重编程中性粒细胞以诱导内源性抗肿瘤免疫
- GSE307049 神经元初级纤毛是稳态可塑性的关键调节因子
- GSE306851 研究发现,ClpP 激活失调可通过代谢竞争耗竭 AML 细胞并恢复 T 细胞功能。
- GSE305772 单细胞 RNA 测序分析 CCl4 诱导的小鼠肝纤维化模型中的肝脏非实质细胞
- 对接受泛整合素αV抑制剂治疗的小鼠肝脏进行GSE305630 scRNA-seq分析,这些小鼠在接受pIVCL治疗后。
- 对接受 pIVCL 治疗后内皮细胞特异性 CTGF KO 小鼠肝脏进行 GSE305482 scRNA-seq 分析
- GSE304023 HERC5-HSP60 ISGylation轴维持胶质母细胞瘤干细胞的线粒体稳态以促进肿瘤进展
- GSE303349 CXCL16驱动的CD4+ T细胞协调针对MHC-I缺陷型肿瘤的免疫监视
- GSE300111 靶向 Menin 治疗 T 细胞系急性淋巴细胞白血病 [menin_treatments]
- GSE300110 靶向 Menin 治疗 T 细胞系急性淋巴细胞白血病 [MEF2COE]
- GSE300109 靶向 Menin 治疗 T 细胞系急性淋巴细胞白血病 [MEF2CKD]
- GSE299228 小鼠肝脏在热量限制和抗血管生成干预后的RNA测序
- GSE298430 三维基质胶赋予人类多能干细胞前原肠胚阶段上胚层特征 [scRNA-seq]
- GSE298429 三维基质胶赋予人类多能干细胞前原肠胚阶段上胚层特征 [批量 RNA 测序]
- GSE298428 三维基质胶赋予人类多能干细胞前原肠胚阶段上胚层特征 [ATAC-seq]
- GSE297933 BRD4 信号维持 β 细胞的分化状态 [scATAC-seq]
- GSE297928 BRD4 信号维持 β 细胞的分化状态 [scRNA-seq]
- GSE296921 LINE-1逆转录转座子作为顺式调控增强子促进SEMA3C表达,从而维持乳腺癌干细胞的存活
- GSE295656 活性依赖性核糖体谱分析揭示脑组织中经典和非经典翻译的概况 [Ribo 和 RNA-Seq]
- GSE295334 RNA测序数据,包括LPS刺激后8周的软脑膜/血管周围CAM和MG,以及细胞增殖后
- GSE294912 RNA测序数据来自缺血性卒中后野生型小鼠的全组织或分离的CAMs。
- GSE294773 脑膜/血管周围绒毛尿囊膜细胞 (CAM) 再植后 8 周的 RNA 测序数据。
- GSE293808 synNotch CAR-巨噬细胞通过增强适应性免疫促进持久的抗肿瘤活性
- GSE292956 特发性肺纤维化(IPF)与供体肺远端外植组织的空间转录组比较
- GSE292748 NtispH 作为烟草(Nicotiana tabacum)腺毛发育和萜类代谢的关键调节因子
- GSE292664 了解和靶向新型 RUNX1 家族性血小板疾病小鼠模型的进展 [小鼠 scRNA]
- GSE292558 WT 和 IGF2BP2 KO 巨噬细胞的转录组分析揭示了代谢改变
- GSE292492 癌症相关的SF3B1突变通过破坏环状RNA生物合成来抑制DNA损伤修复
- GSE292425 人类早期皮层代谢图谱揭示细胞命运转变的调控因子
- GSE292001 分析原代人肾脏祖细胞 (hRPC) 的转录特征 [scRNA-Seq]
- GSE291843 IGF2BP3 通过调节 MYC 表达在结直肠腺瘤细胞的生长异质性中起关键作用 [小鼠 RNA-seq]
- GSE291326 单细胞 RNA 测序分析了接受 pIVCL 手术和假手术的小鼠肝脏非实质细胞。
- GSE291325 人类 FALD 和正常肝脏肝脏组成细胞的单细胞 RNA 测序分析
- GSE291322 RNA-seq 分析暴露于静水压刺激的肝窦内皮细胞
- GSE290306 ZBTB7B 通过上调 GPR17 和 CXCL10 抑制胶质瘤的致瘤性
- GSE288149 白细胞介素 9-ZBTB18 轴促进记忆 B 细胞生发中心发育 [ATAC-seq]
- GSE284409 棒状杆菌介导的抑制金黄色葡萄球菌诱导的慢性鼻窦炎上皮屏障损伤和炎症激活的机制
- GSE282663 METTL3在小鼠植入前发育过程中线粒体功能和表观遗传调控中的关键作用
- GSE269731 从硬脑膜、对照小鼠和感染B族链球菌的小鼠中分离的髓系细胞的单细胞水平基因表达谱
- GSE269398 单核细胞和脑膜巨噬细胞在细菌性脑膜脑炎中的作用
- GSE260951:对不同妊娠结局孕妇血浆样本进行miRNA测序,研究对象为妊娠结局不同的孕妇。该研究对GSE260951组孕妇血浆样本进行了miRNA测序。
- GSE260740 利美吉泮治疗对小鼠肿瘤移植侧三叉神经节基因表达的影响。
- GSE253813 结核分枝杆菌中 Rv0043c、Rv0165c 和 Rv3060c 缺失的转录组分析
- GSE246365 RNA-seq of ER+ PDX models treated with GDC-9545
- GSE246364 RNA-seq 数据,用于分析 ER 敲低或 GDC-9545 处理的 MCF-7 细胞。
- GSE246363 RNA-seq 分析了 ER 或 FOXA1 敲除和/或 GDC-9545 处理的 MCF-7 细胞。
- GSE246362 RNA-seq 分析了用 GDC-9545 和 GNE-858 处理的 MCF-7 细胞
- GSE246361 MCF-7 RPMI ERα 和 FOXA1 ChIP-seq 在 GDC-9545 和 GNE-858 中
- GSE246360 GDC-9545 和 GNE-858 处理的 MCF-7 细胞中 GATA3 的 ChIP-seq
- GSE246359 MCF-7 细胞经 GDC-9545 和 GNE-858 处理的 ATAC-seq
- GSE246358 GDC-9545 处理的 ER+ PDX 模型 ATAC-seq
- GSE230458 代谢性神经病小鼠背根神经节组织的核糖体谱分析
- GSE223631 膳食蛋白质含量对不同免疫参数影响的综合分析
- GSE201708 人类内皮细胞分化的多组学分析揭示了血管相关功能障碍中的基因调控程序 [RNA-Seq]
- GSE201707 人类内皮细胞分化的多组学分析揭示了血管相关功能障碍中的基因调控程序 [ChIP-Seq]
- GSE201706 人类内皮细胞分化的多组学分析揭示了血管相关功能障碍中的基因调控程序 [原位 Hi-C]
- GSE171312 小鼠海马脑组织纳米孔直接RNA测序
- GSE168420 内源性逆转录病毒重塑人-动物嵌合体的早期发育 [RNA-seq]
- GSE168419 内源性逆转录病毒重塑人-动物嵌合体的早期发育 [ATAC-seq]
- GSE157123 人类造血干细胞和祖细胞在出生后发育过程中的单细胞转录组图谱
📅 报告生成时间:2026-03-01 21:41
🤖 由 GitHub Actions 自动生成